Rhode Island Medicaid stopped covering Wegovy, Zepbound, Saxenda, and Foundayo for weight loss on Oct. 1, 2026. Diabetes coverage continues. Here is what members should know.
Rhode Island Medicaid Ends Coverage of Wegovy, Zepbound, and Other GLP-1 Drugs Prescribed Only for Weight Loss
by | Oct 3, 2026 | Uncategorized | 0 comments
Recent Comments